CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Scarpa, S.
Right arrow Articles by Strom, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Scarpa, S.
Right arrow Articles by Strom, R.

Cell Growth & Differentiation, Vol 7, Issue 8 1051-1058, Copyright © 1996 by American Association of Cancer Research


ARTICLES

Simultaneous myogenin expression and overall DNA hypomethylation promote in vitro myoblast differentiation

S Scarpa, M Lucarelli, F Palitti, D Carotti and R Strom
Department of Human Biopathology, University of Rome La Sapienza, Italy.

Two clones of the L5 myoblast line (M6 and the fusion-defective M12) were examined for the expression of myogenin, one of the regulatory genes involved in the regulation of differentiation to myofibers after treatment with 3-deazaadenosine, a metabolic inhibitor of methyl transfer reactions. Cultures treated with 3-deazaadenosine showed, using Northern blot hybridization, a conspicuous increase in myogenin expression, which in clone M6 correlated to the extent of cell differentiation under fusing conditions but was evident also in growth medium, although the drug was unable to start the myogenic program. We also tested the extent of total DNA methylation to verify whether the activation of the regulatory cascade could be correlated to the decrease of the overall number of 5-methylcytosines present in the genome. The results show that the loss of 5-methylcytosine from newly synthesized DNA, but not from preexisting DNA, is evident in fusing conditions and enhanced by 3-deazaadenosine. It appears that there is a positive correlation between the passive demethylation of newly synthesized DNA, the activation of the myogenin gene by demethylation, and the differentiation of myoblasts. However, in fusing conditions, the defective clone M12, although it is able to express myogenin and its DNA is hypomethylated, fuses only in the presence of 3-deazaadenosine, suggesting some alternative way of induction.


This article has been cited by other articles:


Home page
Physiol. GenomicsHome page
I. Terruzzi, P. Senesi, A. Montesano, A. La Torre, G. Alberti, S. Benedini, A. Caumo, I. Fermo, and L. Luzi
Genetic polymorphisms of the enzymes involved in DNA methylation and synthesis in elite athletes
Physiol Genomics, August 24, 2011; 43(16): 965 - 973.
[Abstract] [Full Text] [PDF]


Home page
EMBO J.Home page
S.-W. Luo, C. Zhang, B. Zhang, C.-H. Kim, Y.-Z. Qiu, Q.-S. Du, L. Mei, and W.-C. Xiong
Regulation of heterochromatin remodelling and myogenin expression during muscle differentiation by FAK interaction with MBD2
EMBO J., September 2, 2009; 28(17): 2568 - 2582.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
M. Lucarelli, A. Fuso, R. Strom, and S. Scarpa
The Dynamics of Myogenin Site-specific Demethylation Is Strongly Correlated with Its Expression and with Muscle Differentiation
J. Biol. Chem., March 9, 2001; 276(10): 7500 - 7506.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
M. Lucarelli, A. Fuso, R. Strom, and S. Scarpa
The Dynamics of Myogenin Site-specific Demethylation Is Strongly Correlated with Its Expression and with Muscle Differentiation
J. Biol. Chem., March 9, 2001; 276(10): 7500 - 7506.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1996 by the American Association of Cancer Research.